SARS-CoV-2 Vaccination Seems Safe After MIS-C
No major adverse events seen among 15 children with MIS-C who were subsequently vaccinated against SARS-CoV-2
Rise in U.K. COVID-19 Cases Closely Watched by U.S. Health Officials
U.K. saw a 48 percent increase in COVID-19 cases and a 17 percent rise in hospitalizations last week
Physician’s Briefing Weekly Coronavirus Roundup
Survival High With ECMO for Selected Severe COVID-19 Patients
Of 30 patients, 90 percent survived to discharge; survival was 86.7 percent at median follow-up of 10.8 months since ECMO cannulation
Risk for Decline Up for Low-Income Seniors After ICU Stay
Risks for disability and transition to probable dementia increased after ICU stay for seniors with dual eligibility for Medicare and Medicaid
Exhaustion-Related Burnout Higher in Underrepresented Medical Students
However, medical students who are underrepresented in medicine less likely to report disengagement
Congenital Heart Defect May Up Risk for Critical COVID-19 Illness
Among patients with congenital heart defects, critical COVID-19 outcomes linked to having comorbidities, male sex, age 50 to 64 years
Physician’s Briefing Weekly Coronavirus Roundup
Clinical Quality Up at Hospitals With Research Publications
Hospital research publications linked to lower risk-adjusted mortality rates for several conditions and procedures, higher patient satisfaction
ACP Issues Final Practice Points for Remdesivir Use in COVID-19
Consider treatment with remdesivir for five days for hospitalized COVID-19 patients who do not require invasive ventilation or ECMO
